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Synthetic peptldes. corresponding to the amino acid sequences of the N- and C-termmal parts of the 3rd intracellular loop of the dopamine Dz 
receptor. attenuate dopammergic adenylate cyclase inhibition m membranes Both pepttdes also acttvate directly GTPase acttvity m membranes. 
We suggest a functtonal model for G,-coupled receptors where two sites m the 3rd inner loop compose the links for the receptor-G protein interaction 
thus providing the tools for a selective and adjustable response. Functtonal coupling was not affected by a peptide representing the insert in the 
long form of the dopamine Dz receptor (D_ ,f,c,ne,). The selecttvtty pattern of conventional G protein-linked receptors also sheds some hght on the 
recently observed mteractton of /6amyloid protein precursor (APP) complexes wtth G protems. 
Dopamine D, receptor, G protein; Receptor-G protem couphng: Synthetic peptlde 
1. INTRODUCTION 
Transmembrane signaling of G protein-linked 
receptors proceeds by receptor-G protein-effector 
assemblies coupled through specific protein-protein in- 
teractions along the inner surface of membranes. 
Heterotrimeric regulatory G proteins not only act as 
proportionate transducers of hormone signals. but also 
allow for additional flexibility in adjusting the intracel- 
lular response of a variety of effecters to a variety of 
external signals. Present evidence suggests that the spec- 
ificity and selectivity of receptor-G protein interactions 
are determined by the topology, number and composi- 
tion of potential interaction sites. On the assumption 
that synthetic peptides making up all or part of the 
presumptive receptor-G protein binding sites retain 
structural and functional properties of their origin and 
thus mimic or compete with the receptor, we have previ- 
ously analyzed the inner loop regions of /I-adrenergic 
receptors (PAR) for potential interaction sites in signal 
transmission involving the stimulatory G protein, G, 
[l-3]. G protein associated functions were either decou- 
pled or activated. Disclosing interaction sites with site- 
specific synthetic peptides proved to be useful and ver- 
satile also with other G protein-linked receptors [4-61 
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and for cryptic sequences in G protein-activating pro- 
teins like growth factor receptors [7] and the P-amyloid 
precursor protein (APP) [S]. 
In contrast to hormonal stimulation of adenylate 
cyclase, the components and the sequence of interac- 
tions in adenylate cyclase inhibition are poorly under- 
stood or as yet undetermined [9,10]. In search for the 
G protein interaction sites of inhibitory receptors we 
investigated dopaminergic adenylate cyclase inhibition 
in intact membranes. 
The dopamine D2 receptor (D,R), which is a subtype 
of dopamine receptors [l I] attenuates adenylate cyclase 
activity and modulates other effects. The sequence and 
structure of the D,R have been deduced from the corre- 
sponding cDNA [ 12, for review see 131. In common with 
the topography of the G protein-linked receptor family, 
seven transmembrane domains connected by intra- and 
extracellular loops have been suggested [14-l 51. The 
D,R exists in two forms, Dl,,ong) and DlfshortJ, which are 
generated from the same gene by alternative splicing, 
and which differ from each other only by a 29 amino 
acid insertion in the third intracellular loop [13.16]. This 
insertion is thought to alter the coupling efficiency of 
the two receptor subtypes with G proteins [16,17]. G,, 
has been proposed as a candidate in D&G protein- 
linked signal transduction [ 181. 
In the present study we were able to identify two G 
protein interacting regions in the third inner loop of 
D,R by specific effects on downstream effecters. 
2. MATERIALS AND METHODS 
2.1. Muteriuls 
Peptide synthesis chemicals were from Applied Btosystems and 
Novabtochem Radtochemtcals were from New England Nuclear. 
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Human embryonic kidney 293 cells transfected with and stably ex- 
pressing the D,,,,,,, or Dz,,hOr,, subtype of the DIR were obtained from 
Dr. P. Seeburg [16] and cultured by Dr. T. Voss (Bender & Co. Wien). 
2.2. Peptide synthem 
Peptides were synthesized by the solid-phase Merrtfield method on 
an Applied Btosystems 430A peptide synthesizer as described earlier 
[3]. Purity was based on analytical HPLC, and vertfied by amino acid 
analysts (W. Hoppe. Universitat Wtirzburg) and FAB mass spectrom- 
etry (K.D. Kliippel, GBF, Braunschweig). 
2.3. Membrunr preparation 
Membranes were prepared from monolayer cultures of 293 cells. 
Cells were resuspended with a Polytron homogenizer at setting 6 for 
20 s in phosphate-buffered saline (pH 7.4). 
2.4. Ligand bmdmg 
Membranes (50 fig per assay) were Incubated for 15 min at 37°C 
m 50 mM Trts (pH 7.7) with 0.5 nM [‘Hlsptperone with or without 
10 PM haloperidol to calculate the amount of specific binding. The 
total concentration of receptor-specific bmdmg sites was 3 + 0.5 pmoll 
mg membrane protein. Non-transfected cells dtd not show any specific 
[3H]spiperone binding. 
2.5. Admylute c~&se uctirity 
Adenylate cyclase activity was assayed in membrane suspensions 
(50-70 pg protein/assay) at 30°C for 20 min as described m [3]. 
Hormone-induced activation of the adenylate cyclase system was 
primed with 1 PM PGE, and 50 PM GTP with or without 100 PM 
dopamine. Synthetic peptides were first incubated with membranes for 
60 min at 4°C. For controls, a D,-selective antagonist, 10 PM halo- 
peridol or 10 PM (+/-)sulpiride was added. 
2.6. GTPuse assq 
GTPase activity was determined essentially as described m [l9] and 
[20]. Synthetic peptides were first incubated with membranes for 60 
min at 4°C. GTPase was stimulated by addition of 100pM dopamine 
in the presence of 10 PM propranolol: basal GTPase activity was 
measured m the presence of 10 PM haloperidol and 10 PM propra- 
nolol. The dopamine-stimulated GTPase activity was usually 2-fold 
larger than the basal GTPase activity and was set to 100%. 
3. RESULTS 
Based on our previous studies with synthetic peptides 
on receptor-G protein interactions [3] we made a search 
for conserved structural motifs [21] within the suggested 
structure of the D,R (Fig. 1) by sequence alignment to 
the corresponding regions in PAR. The peptides se- 
lected for synthesis (see below) cover the complete intra- 
cellular loop i2 (i2), the N-terminal part of loop i3 (i3N), 
one half of the unique ‘insertion’ of 29 amino acids in 
the loop i3 of the DlclongJ receptor (i31), the C-terminal 
part of loop i3 (i3C) and the COOH-terminus distal to 
the seventh transmembrane region, forming a putative 
loop (i4). In addition, all peptides except D2/256270 
retain l-5 amino acids of the predicted transmembrane 
a-helical regions of the receptor [15,16]. 
D2/128-152 (i2): ISIDRYTAVAMPMLYNTRYSSK- 
RRV; 
D2/208-226 (i3N): VYIKIYIVLRRRRKRVNTK; 
D2/256270 (i31): IMKSNGSFPVNRRRV; 
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Fig. 1. Location of synthetic pepttdes with respect to the transmem- 
brane topology of the human dopamine Dz receptor [15]. The first 
amino acid of the fragment is indexed, the complete sequences are 
shown as solid circles. Amino acids representing the ‘insert’ m the 
D 2+,ngJ isoform of D,R are marked by shaded and solid circles. 
D2/360-377 (i3C): RRKLSQQKEKKATQMLAI; 
D2/425443 (i4): IYTTFNIEFRKAFLKILHC; 
3.1. D2-peptides response studies and controls 
The effects of peptides were studied in membranes of 
293 cells. which were transfected with and stably ex- 
pressed the longer or the shorter subtype of the D,R at 
similar levels (- 105/cell); membranes from non-trans- 
fected cells served as a control. We found that within the 
experimental limits peptide effects were the same what- 
ever the receptor subtype, therefore only results from 
membranes using cells transfected with DZtlong, receptors 
are presented. With respect to possible interference by 
interactions with related G protein-coupled receptor 
complexes, controls were set up in membranes from 
non-transfected cells (Fig. 2A). In the absence of 
dopamine and at low concentrations all DZ-peptides 
except for D2/208-226 do not interfere with prestimu- 
lated adenylate cyclase. The latter peptide is able to 
stimulate or inhibit adenylate cyclase activities even in 
non-transfected 293 cell membranes. Above 10 PM con- 
centrations all peptides apparently inhibit adenylate 
cyclase in prestimulated membranes. 
3.2. Effects of D2-peptides on G protein mediated 
adenylate cyclase inhibition 
The competence of peptides to uncouple the inhib- 
itory effect of dopamine was judged from their potential 
to neutralize the dopamine dependent inhibition with 
the results shown in Fig. 2B-D. In membranes from 
transfected 293 cells dose-dependent effects were ob- 
served at low peptide concentrations with D2/208-226 
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Fig. 2. (A) Effects of synthetic peptides on prostaglandm E, mediated adenylate cyclase activation in membranes from non-transfected 293 cells. 
(B-D) Effects of synthetic peptides on dopamme dependent adenylate cyclase inhlbitlon in membranes of 293 cells expressing the dopamine DZ,,_, 
receptor. Data are presented as percentage of initial adenylate cyclase activity obtained with 1 PM PGE, m the absence of dopamme and peptides; 
maximal CAMP levels were 70 k 10 pmol/assay for D 2,,ongjR and 60 + 10 pmol/assay for D2CSh,,rt, R. PGE, (open symbols) or PGE, and dopamine 
(filled symbols) were added to membranes preincubated with synthetic peptides. 
t dqomtne + U/208-226 
+ 02/128-152 
-t 02/256&270 
c dapomw + 02 256.270 
+ dopomine + Q2/425-443 
Pepllde (JAI) 
(Fig. 2B) and D2/360&377 (Fig. 2C). The peptide D2/ 
208-226 attenuates dopaminergic adenylate cyclase in- 
hibition already at concentrations lower than 1 PM and 
overcomes the dopamine effect at 2 ,uM. Above 2 ,uM 
adenylate activity was increased (Fig. 2A). Effects on 
D2R decoupling elicited by D2/360-377 require some- 
what higher doses (2-10 PM). Other effects observed at 
even higher concentrations of all peptides might be 
caused by their direct interaction with a broad range of 
G proteins since these effects are of comparable size in 
membranes from transfected as well as non-transfected 
cells and appear independent on the presence of D,R 
and hormone (compare Fig. 2A and D). 
The potency of some receptor mimetic peptides to 
elicit effects in G proteins deserves special attention in 
view of the recent observations of Gilman and Bourne, 
who found that adenylate cyclase (type II or IV) activity 
will be activated by G protein Pr subunits provided that 
G, is also active [10,22]. Since in 293 membranes used 
in this study G,-mediated preactivation of adenylate 
cyclase is necessary, stimulation of other G proteins 
which makes /3y subunits available might be sufficient 
to stimulate or inhibit adenylate cyclase. 
In contrast, peptides comprising loop i2. the middle 
part of loop i3 and the COOH-terminus failed to cause 
changes in dopaminergic adenylate cyclase inhibition at 
0.1-10 PM (Fig. 2D). 
3.3. Effects of D2-peptides on GTPase activity in mem- 
branes 
The peptides D2/208-226 (Fig. 3A) and D2/360-377 
(Fig. 3B) caused a significant increase of the GTPase 
activity in transfected 293 membranes. The up to 2-fold 
stimulation of GTPase activity was independent of the 
presence of dopamine suggesting a direct interaction of 
the peptides with G,z or related G-proteins. A decrease 
of P, formation caused by D2/208-226 was observed at 
concentrations beyond the range where adenylate 
cyclase inhibition was decoupled (Figs. 2B and 3A). 
Peptides D2/128-152, D2/256-270 and D21425443 
showed no significant effect in the same concentration 
range (Fig. 2C). The fact, that only peptides affecting 
adenylate cyclase were also effective in GTPase activa- 
tion, is in good agreement with our assessment of the 
adenylate cyclase inhibition studies. 
4. DISCUSSION 
To assess the topology of intracellular receptor se- 
quences involved in determining G protein selectivity 
we focused on a comparison of differential responses to 
synthetic peptide fragments of two receptor prototypes 
both modulating adenylate cyclase activity: PAR func- 
tioning primarily as a stimulatory receptor and D,R 
functioning predominantly as an inhibitory receptor. 
Supplementing earlier investigations, our results 
clearly display which sites in PAR [3] or D,R are poten- 
tially involved in G protein interaction and which sites 
can be excluded. Previously, we could not find effects 
elicited by peptides from loop il of PAR, except a very 
weak inhibition [l], which might be due to partial simi- 
larity to a motif composed of positively charged resi- 
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Fig. 3. Effects of synthetic peptides on GTPase actrvny m membranes from 193 cells expressmg the dopamme D:,,,,,,, receptor Imtial GTPase actrvrty 
was measured at 100 PM dopamme without peptides. The maxtmal dopamme-sttmulated “P, levels obtained after IO mm incubatron were 
1.08 f 0.15 pmol/assay for DZthing) R and I 14 k 0.15 pmol/assay for Dzc,h,n, R Membranes were Incubated wnh 100 PM dopamme (filled symbols) 
or IO ,uM haloperrdol (open symbol,). 
dues interspaced by neutral residues [23]. Therefore, 
cryptic functions of loop il were not studied with pep- 
tides from D,R. Peptides from loop i2 were effective 
only in the stimulatory branch. Effects caused by the 
N-terminal and C-terminal peptides of loop i3 indicate 
the essential character of these regions for signal trans- 
fer in both prototypes. Supplementary studies with a 
peptide representing part of the insert in loop i3 of 
D Z(,ongj)R, which has been hypothesized to encode part 
of the specifying message, were negative; these results 
imply that the insert does not engage in direct interac- 
tions with a binding site on a G protein. Accordingly, 
all results using either membranes from Dl(,ongj- or 
D Z(,,,,,tj-transfected cells were identical. Small differ- 
ences in receptor-G protein coupling between the short 
and long forms of D,R were reported by Castro and 
Strange, presumably reflecting differences in structure 
of loop i3 [17]. Finally, peptides derived from loop i4 
were effective only in case ofpAR. Since the D,R does 
not extend beyond loop i4, common receptor-G protein 
interaction sites are unlikely to be located in the far 
C-terminal region of G protein linked receptors. 
Unlike the well-documented contributions from the 
2nd. 3rd and 4th inner loops of the structurally related 
BAR to signal transduction in the stimulatory branch 
of adenylate cyclase control [1,3], we could identify and 
locate only two regions within the loop i3 that are in- 
volved in dopaminergic inhibition of adenylate cyclase 
activity in membranes. Therefore, it appears that a 
rather limited number of subsites are already sufficient 
to specify the interactions in the inhibitory branch. The 
present results do not finally settle the question of how 
many receptor sites are required to confer selectivity for 
signal transduction: however, as far as conserved mem- 
brane-attached sites of inner loops are involved, the 
present selection of peptides provides a complete cover- 
age of all potential sites. No interaction sites have been 
reported for the non-conserved parts of loop i3, more- 
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over, these regions can be removed by proteolysis or 
deletion mutagenesis without loss of regulatory func- 
tion [9]. 
Analysis of the results from adenylate cyclase modu- 
lation and GTPase activation or inhibition allows some 
further specification of the presumed functional interac- 
tions of loop i3 regions. The effects of D2/208-226 
below 2 PM apparently quench dopaminergic inhibition 
and thus appear to be specific for D,R-G protein cou- 
pling; above 2 PM the peptide stimulates adenylate 
cyclase activity even in non-transfected membranes. 
The effects of D2/360-377 (Fig. 2C) below 10 FM are 
equally specific in attenuation of the dopaminergic inhi- 
bition of adenylate cyclase. It is tempting to speculate 
that the observed dose dependence of different G pro- 
tein associated effects might also play a role in specify- 
ing the selective response. In the present case, interac- 
tion with the N-terminal region of loop i3 (D2/208-326) 
makes the response specific for dopaminergic adenylate 
cyclase inhibition. consequent interaction of a second 
receptor domain (C-terminal part of loop i3, repre- 
sented by D2/360-377) will be confined to the same G 
protein molecule, whatever the preference of the syn- 
thetic peptide at higher concentrations may be [24]. 
G protein interactive sites were consistently found in 
all related G protein receptors like rhodopsin [5]. /&AR 
[6], M,AChR [23] and +AR [35]. The fact that many 
of these sites share conserved sequences within related 
receptors and therefore must share conserved recogni- 
tion sites on the G protein surface was explored for 
proposing one or a few consensus motifs for G protein 
interaction [23]. Consequently, in addition to G protein 
interactive peptides, such as venom peptide toxins 
[26,27] and neuroactive peptides [28]. sequences of sin- 
gle transmembrane spanning receptors were found 
which are similarly interactive with G proteins [7]. The 
latest acquisition to these sequences was the interaction 
of B-amyloid precursor protein (APP) derived se- 
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quences or their mutations with G, [8]. It is still a matter 
of speculation if the latter interactions are essentially 
mimetic or constitute a second class of receptor-G pro- 
tein signaling, or serve the regulation of membrane traf- 
fic [8,29]. Unlike the at least two-sited interaction of 
conventional G protein receptors, a single site interac- 
tion of the latter is sufficient to elicit a G protein re- 
sponse. 
In view of these considerations the present study can 
make a valuable contribution for the evaluation of the 
topology of conventional G protein receptor interaction 
sites, especially towards a discrimination of the stimula- 
tory and inhibitory path of adenylate cyclase control. 
Our present results and related studies from this and 
other laboratories can be treated as special cases of a 
more general strategy to confer specificity and selectiv- 
ity to receptor-G protein coupling [1,3,5,30,31]. To 
meet these requirements all receptors share distinct G 
protein binding domains which reflect structural simi- 
larities of heterotrimeric G protein subtypes; on the 
basis of related homologous sequences, single domains 
might be slightly altered to provide selectivity [9]. There 
is a need for multiple points of interaction; the organisa- 
tion of these domains may vary between different 
classes of G protein-linked receptors. Both points are of 
special relevance for a selective interaction with a dis- 
tinct member from a variety of G proteins. Examples 
for the general case were provided by rhodopsinG, [5] 
and BAR-G, [3] interaction; in both cases effects of the 
corresponding receptor peptides were synergistic and 
supported a simultaneous multisite attack. In receptors 
which are functionally linked to attenuation of adenyl- 
ate cyclase activity like D,R two sites in loop i3 are 
sufficient for G protein selectivity [23.30-321. 
Acknowledgements: We thank Dr. A.P. Czermlofsky and Dr. T. Voss, 
Bender & Co, for valuable contributions during the investigation and 
discussion of this work. We acknowledge FAB mass spectrometry 
analysis of peptides by Dr. K.D. Kliippel, GBF Braunschweig. This 
work was supported by grants from the Deutsche Forschungsgemem- 
schaft, SFB 176, Project A15, and by Bender & Co, Boehringer Ingel- 
helm Group, Vienna, Austria. 
REFERENCES 
[l] Palm, D.. Munch, G.. Dees, C. and Hekman, M. (1989) FEBS 
Lett. 254, 89-93. 
[2] Palm, D., Munch, G., Malek. D., Dees, C. and Hekman, M. 
(1990) FEBS Lett. 261.294298. 
[3] Munch, G., Dees. C., Hekman, M. and Palm. D. (1991) Eur. J. 
Biochem. 198, 357-364. 
[41 
[51 
Fd 
[71 
VI 
[91 
VOI 
[111 
[I21 
u31 
u41 
u51 
1161 
u71 
[I81 
u91 
PO1 
Pll 
PI 
~231 
(241 
v51 
PI 
P71 
WV 
~291 
[301 
[311 
~321 
Hamm, H E., Deretic. D., Arendt, A., Hargrave, PA., Konig, B. 
and Hofman, K.P (1988) Science 241, 832-835 
Konig. B . Arendt, A., McDowell. J.H., Kahlert, M.. Hargrave, 
P.A. and Hofman, K P (1989) Proc. Nat]. Acad. Sci. USA 86, 
6878-6882. 
Cheung, A.H., Huang, R.-R.C., Graziano, M.P. and Strader, 
CD. (1991) FEBS Lett. 279. 2777280. 
Okamoto. T., Katada, T., Murayama, Y., Ui, M., Ogata. E. and 
Nishimoto. 1. (1990) Cell 62, 709-717. 
Nishimoto, I., Okamoto. T., Matsuura. Y., Takahashi. S.. 
Okamoto T., Murayama. Y.. and Ogata E. (1993) Nature 362, 
75579. 
Ross, E.M (1989) Neuron 3. 141-152. 
Birnbaumer, L. (1992) Cell 71. 1069-1072. 
Kebabian, J.W. and Came. D.B. (1979) Nature 277, 93-96. 
Bunzow, J.R., Van Tol, H.H.M., Grandy, D.K., Albert, P., 
Salon, J., Christie. M., Machida, C.A., Neve, K.A. and Civelli, 
0. (1988) Nature 336. 783-787. 
Strange, P.G. (1990) Trends Neurosci. 13, 3733378. 
Letkowitz. R.J. and Caron, M.G. (1988) J. Biol. Chem. 262, 
49934996. 
Zhou. Q.-Y., Grandy, D.K., Thambi. L., Kushner, J.A., Van Tol, 
H.H.M., Cone. R . Pribnow, D., Salon, J.. Bunzow, J.R. and 
Civelh. 0. (1990) Nature 347, 76-80. 
Dal Toso, R., Sommer, B., Ewert, M., Herb. A., Pritchett, D.B., 
Bach. A., Shivers, B.D. and Seeburg. P.H (1989) EMBO J. 8, 
40254034 
Castro. S.W. and Strange. P.G. (1993) FEBS Lett. 315, 2233226. 
Senogles. S E., Spiegel, A.M.. Padrell, E., Iyengar, R. and Caron, 
M.G. (1990) J. Biol. Chem. 265, 45074514. 
Cassel. D. and Selinger, Z. (1976) Biochim. Btophys. Acta 452, 
5388551. 
Hekman. M., Holzhofer, A.. Gierschik. P, Im, M.-J., Jakobs, 
K.-H . Pfeuffer, T. and Helmreich, E.J.M. (1987) Eur. J. Bio- 
them. 169, 431439. 
Probst, W.C., Snyder. LA.. Schuster, D.I., Brosius, J. and Seal- 
fon, S.C. (1992) DNA Cell Biol. 1 I. I-20. 
Hepler. J.R. and Gilman, A.G. (1992) Trends Biol. Sci. 17, 3833 
387. 
Okamoto, T. and Nishimoto, I. (1992) J. Biol. Chem. 267. 8342- 
8346. 
Bonner, TI. (1992) Trends Pharmacol. SC]. 13. 48850. 
Ikezu, T., Okamoto, T.. Ogata. E. and Ntshimoto, I. (1992) FEBS 
Lett. 311. 29932. 
HigashiJima, T., Uzu, S., NkaJima, T. and Ross, E.M (1988) J. 
Biol. Chem. 263, 6491-6494 
Higashijima, T. and Ross. E.J. (1991) J. Biol. Chem. 266, 12655- 
12661. 
Mouslr. M., Bueb, J.-L., Bronner. C., Rouot. B. and Landry, Y. 
(1990) Trends Pharma col. Sci. 11. 358-362. 
Hanley M.R. and Selkoe D.J. (1993) Nature 362, 1415. 
Wess, J., Bonner, T.I., Dorje, F. and Brann, M.R. (1990) Mol. 
Pharmacol. 38, 517-523. 
Lechleiter. J.. Hellmiss. R.. Duerson. K., Ennulat, D.. David, N.. 
Clapham. D and Peralta, E. (1990) EMBO J. 9. 43814390. 
Kubo. T., Bujo. H., Akiba, I., Nakai, J., Mishina, M. and Numa, 
S. (1988) FEBS Lett. 241, 119-125. 
219 
